Company Deep Dive

Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.

Request Deep Dive(50 Feathers)

NXG.V

STRONG BUYREMOVE

NexgenRx Inc. · Healthcare · Canada · $37M · Avg Vol: $31K/d

99
StockRank
Get insider-trade alerts
Q
84
V
47
M
88
P/E (TTM)
35.0x
ROE
23.5%
D/E
0.0x
Dividend %
2.3%
Dir. Trades · 180d
None →
Buybacks · 180d
None →
AI CONVICTION THESIS

Micro-cap with limited information on competitive advantage. While earnings are growing, it does not demonstrate the 'Tenbagger' potential or the durable, un-copyable moat required to meet our strict burden of proof.

Loading 1Y...
PRICE (1Y)+44.4%
0.320.360.400.450.49Jun 11Jul 3Jul 23
SMA 50SMA 200
Close
$0.481
RSI (14)
94.7
52W High
$0.555
From 52W High
0.9%

SCORE BREAKDOWN

Quality
84
ROIC
33.7%97.2
ROE
23.5%91.2
GP/Assets
42.5%82.5
Op. Margin
25.0%88.5
FCF/Assets
12.7%91.0
Piotroski
497.4
Int. Cover
50.0x88.8
D/E Ratio
0.04x73.2
Current Ratio
1.16x15.4
Value
47
P/E (TTM)
35.0x31.6
EV/EBITDA
16.2x40.1
P/FCF
10.8x80.9
P/B
6.9x18.5
P/S
2.7x59.2
Div Yield
2.3%52.7
Momentum
88
52W High %
87%80.2
RS 6M
76%96.8
SMA 50/200
1.17x87.3
EPS Rev 4W
—N/A
EPS Rev 12W
—N/A
EPS Improve
—N/A
Q Growth
133%88.5

FUNDAMENTALS

Market Cap
$37M
P/E (Forward)
—
Gross Margin
84.3%

SECTOR PEERS

Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of NXG.V are excluded.

TickerCompanyMkt CapStockRankSignal
NXG.VNexgenRx Inc.(you)$37M99STRONG BUY
VST.CNVictory Square Technologies Inc.$51M53HOLD
AIDR.CNRocket Doctor AI Inc.$44M7STRONG SELL
WOLF.VGrey Wolf Health Corp.$43M97STRONG BUY
RX.VBioSyent Inc.$124M93STRONG BUY
DR.TOMedical Facilities Corporation$233M100STRONG BUY
CRRX.TOCareRx Corporation$159M89STRONG BUY
HLS.TOHLS Therapeutics Inc.$95M73BUY
CPH.TOCipher Pharmaceuticals Inc.$305M91STRONG BUY
DB.VDecibel Cannabis Company Inc.$50M44HOLD

Peer medians: ROE -44.7% · P/E 16.5x · Gross margin 38.9%

NexgenRx Inc. (NXG.V) — Stock Score Summary

NexgenRx Inc. (NXG.V) has a MoatMap StockRank of 99/100 based on Quality (84/100), Value (47/100), and Momentum (88/100) factor scores. The current signal is STRONG BUY. Micro-cap with limited information on competitive advantage. While earnings are growing, it does not demonstrate the 'Tenbagger' potential or the durable, un-copyable moat required to meet our strict burden of proof.

Key Financial Metrics

Price$0.48
Market Cap$37M
P/E (TTM)35.00
Price/Book6.93
Return on Equity23.5%
Return on Invested Capital33.7%
Debt/Equity0.04x
Gross Margin84.3%
Operating Margin25.0%
Revenue Growth11.6%
Dividend Yield2.3%
Free Cash Flow$3M

NexgenRx Inc. operates in the Health Information Services industry, part of the Healthcare sector (Canada).

Frequently Asked Questions

What is NexgenRx Inc.’s (NXG.V) StockRank?
MoatMap’s StockRank for NexgenRx Inc. (NXG.V) is 99/100, with a Strong Buy signal. It is a composite of Quality (84), Value (47), and Momentum (88) factor ranks across MoatMap’s 20,000+ stock universe.
Does NexgenRx Inc. have an economic moat?
NexgenRx Inc. (NXG.V) has a Quality factor score of 84/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is NexgenRx Inc. a buy, hold, or sell?
MoatMap’s current signal for NexgenRx Inc. (NXG.V) is Strong Buy, based on a StockRank of 99/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is NexgenRx Inc. in?
NexgenRx Inc. (NXG.V) operates in the Healthcare sector, specifically the Health Information Services industry (Canada).
Browse all ranked stocksNXG.V deep dive reportAI ChampionsHow we score stocksSense-check another stock